Kunst, Ines
Krebs, Michael http://orcid.org/0000-0002-9265-7274
Dreschl, Bettina
Prager, Gerhard
Meyer, Elias
Kautzky-Willer, Alexandra
Ranzenberger-Haider, Tamara
Funding for this research was provided by:
Medical University of Vienna
Article History
Received: 2 February 2021
Revised: 24 March 2021
Accepted: 24 March 2021
First Online: 5 April 2021
Declarations
:
: Retrospective analysis of patient data was approved by the ethics committee of the Medical University of Vienna (1361/2018).
: Patients agreed to the data collection in an interdisciplinary electronic registry of the Medical University of Vienna.
: Ines Kunst declares no conflict of interest. Michael Krebs has received research support from Sanofi, AstraZeneca, Fit for Me and Ipsen as well as speaker and consulting fees from AstraZeneca, Novartis, Novo Nordisk, Lilly, Merck, Böhringer, Roche and Sano. Bettina Dreschl declares no conflict of interest. Gerhard Prager declares no conflict of interest. Elias Meyer reports funding for unrelated research from Novartis. Alexandra Kautzky-Willer declares no conflict of interest. Tamara Ranzenberger-Haider declares no conflict of interest.